LIPOPREDICT: Prediction of patients’ response to liposomal antineoplastic drugs: Focusing on the endocytic activity of LRP1B (Q2906914): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: budget (P474): 203,732.7 euro) |
(Changed an Item: modifying budgets in portugal one item from slovenia) |
||||||
Property / budget | |||||||
239,686.0 Euro
| |||||||
Property / budget: 239,686.0 Euro / rank | |||||||
Normal rank | |||||||
Property / EU contribution | |||||||
203,733.0 Euro
| |||||||
Property / EU contribution: 203,733.0 Euro / rank | |||||||
Normal rank | |||||||
Property / co-financing rate | |||||||
85.0 percent
| |||||||
Property / co-financing rate: 85.0 percent / rank | |||||||
Normal rank |
Revision as of 22:31, 21 October 2021
Project Q2906914 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | LIPOPREDICT: Prediction of patients’ response to liposomal antineoplastic drugs: Focusing on the endocytic activity of LRP1B |
Project Q2906914 in Portugal |
Statements
203,733.0 Euro
0 references
239,686.0 Euro
0 references
85.0 percent
0 references
15 July 2018
0 references
14 July 2021
0 references
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
0 references
Q2993205 (Deleted Item)
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-031520
0 references